Last reviewed · How we verify
NCT06778785
Game-Based Digital Intervention for Depression in Adolescents
NA trial testing Digital Intervention in Depression in 450 participants. Participants enrolled and being followed up; not accepting new ones.
30 December 2024
Quick facts
| Lead sponsor | Adai Technology (Beijing) Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 450 |
| Start date | 17 April 2024 |
| Primary completion | 30 December 2024 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Digital Intervention
- Health Education
- Personalization Algorithm
Conditions studied
- Depression — all drugs for Depression →
- Anxiety — all drugs for Anxiety →
Sponsor
Adai Technology (Beijing) Co., Ltd.
Who can join
Adults 10 to 18, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the effectiveness of digital interventions in treating depression and anxiety in adolescents. The main question it aims to answer is: Can digital interventions effectively alleviate symptoms of depression and anxiety in adolescents? The trial will include a comparison group where researchers will compare the effects of the digital intervention to traditional health education methods to assess their relative efficacy. Participants will be asked to engage with the digital intervention platform for a period of two months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06778785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Digital Intervention
Trials testing the same drug.
- NCT06631339 — Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN) · NA · recruiting
- NCT06349993 — Digital Intervention for Depression and Anxiety in Adolescents · NA · recruiting
- NCT05667363 — Digital Therapeutics on Inhalation Medication Adherence in COPD · NA · unknown
- NCT05386706 — Treating PCOS With Digital Intervention vs. Metformin · NA · completed
- NCT04098016 — Digital Intervention To Improve Diet Quality · NA · completed
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other Adai Technology (Beijing) Co., Ltd. trials
Trials by the same sponsor.
- NCT07319325 — Efficacy of Adaptive, Gamified Digital Therapeutics Intervention for Individuals With Methamphetamine Use Disorder in Co · NA · completed
- NCT06349993 — Digital Intervention for Depression and Anxiety in Adolescents · NA · recruiting
- NCT06423443 — Digital Cognitive Behavioral Therapy for Depressive Disorders · NA · recruiting
- NCT06301555 — Game-Based Digital Intervention for Relieving Depression and Anxiety Symptoms · NA · completed
- NCT05554289 — Efficacy, Safety, and Acceptability of Internet-based Cognitive Behavioral Therapy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06778785 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Adai Technology (Beijing) Co., Ltd.
- Last refreshed: 17 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06778785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing